Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-12-07 5:05 pm Sale | 13D | LIQUIDIA CORPORATION COM LQDA | Caligan Partners LP | 7,167,663 13.9% | -1,160,755 (-13.94%) | View |
| 2021-05-10 5:20 pm Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Caligan Partners LP | 8,380,265 11.2% | 8,380,265 (New Position) | View |
| 2021-04-15 08:00 am Purchase | 13D | LIQUIDIA CORPORATION COM LQDA | Caligan Partners LP | 8,328,418 16.1% | 8,328,418 (New Position) | View |
| 2020-11-16 4:38 pm Sale | 13D | AMAG PHARMACEUTICALS INC AMAG | Caligan Partners LP | 0 0% | -3,519,287 (Position Closed) | View |
| 2019-10-10 4:32 pm Purchase | 13D | AMAG PHARMACEUTICALS INC AMAG | Caligan Partners LP | 3,519,287 10.4% | 19,859 (+0.57%) | View |
| 2019-09-30 5:15 pm Sale | 13D | KNOWLES CORP KN | Caligan Partners LP | 4,316,236 4.7% | -305,342 (-6.61%) | View |
| 2019-09-04 08:15 am Unchanged | 13D | AMAG PHARMACEUTICALS INC AMAG | Caligan Partners LP | 3,499,428 10.3% | 0 (Unchanged) | View |
| 2019-08-15 3:00 pm Purchase | 13D | AMAG PHARMACEUTICALS INC AMAG | Caligan Partners LP | 3,499,428 10.3% | 3,499,428 (New Position) | View |
| 2019-05-09 09:30 am Purchase | 13D | KNOWLES CORP KN | Caligan Partners LP | 4,621,578 5.1% | 576,235 (+14.24%) | View |